Raleigh-based UVision360 has achieved a dual-indication clearance from the U.S. Food and Drug Administration for its all-in-one LUMINELLE DTx Hysteroscopy System to be used clinically for hysteroscopy and cystoscopy in women.
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
September 11, 2018
September 10, 2018
Durham-based Mycovia Pharmaceuticals, formerly Viamet Pharmaceuticals, has begun two Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women.
September 7, 2018
North Carolina Central University will soon make it easier for area biopharmaceutical companies to fill job vacancies with qualified employees via online courses offered through NCCU’s Biomanufacturing Research Institute and Technology Enterprise (BRITE).
September 6, 2018
Grifols, a global biotherapeutics company with major operations in North Carolina, has received approval from the U.S. Food and Drug Administration for a new formulation of GamaSTAN, its medicine for treating patients who’ve been exposed to the hepatitis A or measles viruses.
September 5, 2018
A novel drug candidate aimed at preventing and treating hereditary angioedema (HAE) – a recurrent and severe swelling disorder – has shown positive results in a clinical trial, according to its Durham-based developer, BioCryst
September 4, 2018
Research Triangle Park-based CertriRx recently started doing business as Verinetics. But the young company hasn’t changed its focus, or the speed with which it is making inroads in anti-counterfeiting technology.
August 31, 2018
Ken Hoffman, a veteran of the clinical diagnostics industry, was living and working in Boston some 20 years ago when he chose to move his new startup company, Cygnus Technologies, to the small North Carolina coastal community of Southport to enjoy a different lifestyle. It led to big-time success and growth.
August 28, 2018
As the co-founder, CEO and board chair of Javara Inc., a privately funded Winston-Salem clinical research services firm, Jennifer Byrne is convinced her company’s newly minted “Integrated Research Organization" platform offers a more-effective solution to the immense challenges of patient enrollment in clinical trials.
August 24, 2018
As algae blooms fed by chemical fertilizer runoff from farms and lawns contaminate more waterways every year, Mirimichi Green Express is rooting its future in high-end eco-sensitive plant-growing products in the Southeastern North Carolina community of Castle Hayne, near Wilmington.
August 22, 2018
Durham-based 410 Medical, developer of a new medical device for treating critically ill patients, has raised $3.1 million in new financing to commercialize the product.
August 17, 2018
A simple idea became a life-changing one for a young Duke physician assistant who never planned to do anything but practice medicine. Now Shawn Gage is not only an inventor, but an entrepreneur too.
August 17, 2018
Aerie Pharmaceuticals, an ophthalmic pharmaceutical company based in Durham, has reported positive clinical results for Rhopressa, its once-daily eye drop approved for the reduction of elevated eye pressure, a cause of glaucoma.
August 15, 2018
Hernan Navarro, Ph.D., retired chief scientist for RTI International’s Center for Drug Discovery, has returned to the workplace to direct the Biomedical Research Institute and Technology Enterprise (BRITE) at North Carolina Central University in Durham.
August 15, 2018
Raleigh-based Eva Garland Consulting (EGC) is on the prestigious Inc. 5000 list of the country’s fastest-growing private companies.
August 13, 2018
North Carolina is home to six of the top 10 community colleges in the nation, according to SmartAsset, an online site aimed at helping people make smart financial decisions.